litlas
Log inCreate account

Maya H Buch

Active 2002–2026

Also published as
Maya H. Buch
108
Papers
19,619
Citations
56
h-index
99
i10-index

Citations

Citations per year for Maya H Buch1998: 2 citations2003: 2 citations2004: 10 citations2005: 15 citations2006: 18 citations2007: 16 citations2008: 22 citations2009: 35 citations2010: 41 citations2011: 77 citations2012: 66 citations2013: 86 citations2014: 112 citations2015: 144 citations2016: 105 citations2017: 138 citations2018: 87 citations2019: 357 citations2020: 479 citations2021: 788 citations2022: 713 citations2023: 582 citations2024: 985 citations2025: 552 citations2026: 21 citations1999–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,228 citing papers, 13.7% of this breakdownUnited Kingdom: 925 citing papers, 10.3% of this breakdownChina: 613 citing papers, 6.9% of this breakdownItaly: 572 citing papers, 6.4% of this breakdownGermany: 468 citing papers, 5.2% of this breakdownFrance: 449 citing papers, 5% of this breakdownNetherlands: 425 citing papers, 4.8% of this breakdownJapan: 390 citing papers, 4.4% of this breakdownSpain: 300 citing papers, 3.4% of this breakdownCanada: 299 citing papers, 3.3% of this breakdownSwitzerland: 214 citing papers, 2.4% of this breakdownAustralia: 207 citing papers, 2.3% of this breakdown
0%13.7%Other 31.9%

Institutions

Fields

  • Medicine81.1%
  • Biochemistry, Genetics and Molecular Biology7.6%
  • Immunology and Microbiology6.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.8%
  • Computer Science0.4%
  • Other2.3%

Topics

  • Rheumatoid Arthritis Research and Therapies17.7%
  • Systemic Lupus Erythematosus Research5.6%
  • Spondyloarthritis Studies and Treatments5.5%
  • Autoimmune and Inflammatory Disorders Research5.1%
  • Systemic Sclerosis and Related Diseases2.7%
  • COVID-19 Clinical Research Studies2.1%
  • Other61.3%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    Authors: Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 cited by 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    Authors: Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 cited by 2,766

  3. EULAR definition of difficult-to-treat rheumatoid arthritis

    Authors: György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes, Alison Kent, Margôt Bakkers, Etienne Blaas, Ladislav Šenolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W. G. Jacobs, Rinie Geenen, Hans Bijlsma, A. Zink, Daniel Aletaha, Leonard Schoneveld, Piet L. C. M. van Riel, Loriane Gutermann, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Georg Schett, Kimme L Hyrich, Ulf Müeller-Ladner, Maya H Buch, Iain B. McInnes, Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2020 cited by 539

  4. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    Authors: Felice Rivellese, Anna E. A. Surace, Katriona Goldmann, Elisabetta Sciacca, Cankut Çubuk, Giovanni Giorli, Christopher R. John, Alessandra Nerviani, Liliane Fossati‐Jimack, Georgina Thorborn, Manzoor Ahmed, Edoardo Prediletto, S. Church, Briana M. Hudson, Sarah Warren, Paul McKeigue, Frances Humby, Michele Bombardieri, Michael R. Barnes, Myles Lewis, Costantino Pitzalis, the R4RA collaborative group, Felice Rivellese, Giovanni Giorli, Alessandra Nerviani, Liliane Fossati‐Jimack, Georgina Thorborn, Frances Humby, Michele Bombardieri, Myles Lewis, Patrick Durez, Maya H Buch, Hasan Rizvi, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Vasco C. Romão, João Eurico Fonseca, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar DasGupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Julio Ramírez, Raquel Celis, Robert J. Moots, Peter C. Taylor, C J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Gaye Hadfield, Costantino Pitzalis - Nature Medicine 2022 cited by 279

  5. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    Authors: Frances Humby, Patrick Durez, Maya H Buch, Myles Lewis, Hasan Rizvi, Felice Rivellese, Alessandra Nerviani, Giovanni Giorli, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Michele Bombardieri, Vasco C. Romão, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar Dasgupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Robert J. Moots, Peter C. Taylor, Christopher J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Costantino Pitzalis, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, João Eurico Fonseca, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Liliane Fossati‐Jimack, Gaye Hadfield, Georgina Thorborn, Julio Ramírez, Raquel Celis - The Lancet 2021 cited by 315

  6. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis

    Authors: Maya H Buch, Stephen Eyre, Dennis McGonagle - Nature Reviews Rheumatology 2020 cited by 304

  7. Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

    Authors: Andrew P. Cope, Marianna Jasenecova, Joana C. Vasconcelos, Andrew Filer, Karim Raza, Sumera Qureshi, Maria Antonietta D’Agostino, Iain B. McInnes, John D. Isaacs, Arthur G. Pratt, Benjamin A. Fisher, Christopher D. Buckley, Paul Emery, Pauline Ho, Maya H Buch, Coziana Ciurtin, Dirkjan van Schaardenburg, Thomas Huizinga, René E. M. Toes, Evangelos Georgiou, Joanna Kelly, Caroline Murphy, A Toby Prevost, Sam Norton, Heidi Lempp, Maria Opena, Sujith Subesinghe, Toby Garrood, Bina Menon, Nora Ng, Karen M. Douglas, Christos Koutsianas, Faye A. H. Cooles, Marie Falahee, Irene Echavez-Naguicnic, Anurag Bharadwaj, Michael Villaruel, Ira Pande, David Collins, Suzannah Pegler, Sabrina Raizada, Stefan Siebert, G. Fragoulis, Jesusa Guinto, James Galloway, Andrew I Rutherford, Theresa Barnes, Helen Jeffrey, Yusuf Patel, Michael Batley, Brendan O'Reilly, Srivinisan Venkatachalam, Thomas Sheeran, Claire Gorman, Piero Reynolds, Asad Khan, Nicola Gullick, Siwalik Banerjee, Kulveer Mankia, Deepak Jordan, Jane Rowlands, Mirian Starmans‐Kool, James C. Taylor, Pradip Nandi, Ilfita Sahbudin, Mark Maybury, Samantha Hider, Ann Barcroft, Jeremy McNally, Jo Kitchen, Muhammad Nisar, Vanessa Quick - The Lancet 2024 cited by 160

  8. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

    Authors: György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes, Alison Kent, Margôt Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Šenolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W. G. Jacobs, Rinie Geenen, J. W. J. Bijlsma, A. Zink, Daniel Aletaha, Leonard Schoneveld, Piet L. C. M. van Riel, Sophie Dumas, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Georg Schett, Kimme L Hyrich, Ulf Müeller-Ladner, Maya H Buch, Iain B. McInnes, Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2021 cited by 276

  9. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

    Authors: Christina Charles‐Schoeman, Maya H Buch, Maxime Dougados, Deepak L. Bhatt, Jon T. Giles, Steven R. Ytterberg, Gary G. Koch, Ivana Vranić, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Jose L. Rivas, Arne Yndestad, Carol A. Connell, Zoltán Szekanecz - Annals of the Rheumatic Diseases 2022 cited by 204

  10. Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

    Authors: Zoltán Szekanecz, Maya H Buch, Christina Charles‐Schoeman, James Galloway, George Karpouzas, Lars Erik Kristensen, Steven R. Ytterberg, Attila Hamar, Roy Fleischmann - Nature Reviews Rheumatology 2024 cited by 128

  11. Drug-Induced Interstitial Lung Disease: A Systematic Review

    Authors: Sarah Skeoch, Nicholas Weatherley, Andrew J. Swift, Alexander Oldroyd, Christopher Johns, Conal Hayton, Alessandro Giollo, James M. Wild, John C. Waterton, Maya H Buch, Kim Linton, Ian N Bruce, C.T. Leonard, Stephen Bianchi, Nazia Chaudhuri - Journal of Clinical Medicine 2018 cited by 408

  12. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

    Authors: Maxime Dougados, Martin Soubrier, Anna Antunez, Péter Bálint, Alejandro Balsa, Maya H Buch, Gustavo Casado, J. Detert, Bassel Elzorkany, Paul Emery, N. Hajjaj‐Hassouni, Masayoshi Harigai, Shue‐Fen Luo, Réka Kurucz, Gabriel Maciel, Emilio Martín Mola, Carlomaurizio Montecucco, Iain B. McInnes, Helga Radner, Josef S Smolen, Yeong-Wook Song, Harald E. Vonkeman, Kevin Winthrop, Jonathan Kay - Annals of the Rheumatic Diseases 2013 cited by 858

  13. Synovial tissue research: a state-of-the-art review

    Authors: Carl Orr, Elsa Vieira‐Sousa, David L. Boyle, Maya H Buch, Christopher D. Buckley, Juan D. Cañete, Anca I. Catrina, Ernest Choy, Paul Emery, Ursula Fearon, Andrew Filer, Daniëlle M. Gerlag, Frances Humby, John D. Isaacs, Søren Andreas Just, Bernard Lauwerys, Benoît Le Goff, Antonio Manzo, Trudy McGarry, Iain B. McInnes, Aurélie Najm, Costantino Pitzalis, Arthur G. Pratt, Malcolm Smith, Paul P. Tak, Sander W. Tas, Rogier M. Thurlings, João Eurico Fonseca, Douglas J. Veale - Nature Reviews Rheumatology 2017 cited by 257

  14. Defining refractory rheumatoid arthritis

    Authors: Maya H Buch - Annals of the Rheumatic Diseases 2018 cited by 185

  15. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

    Authors: Felice Rivellese, Alessandra Nerviani, Giovanni Giorli, Louise Warren, Edyta Jaworska, Michele Bombardieri, Myles Lewis, Frances Humby, Arthur G. Pratt, Andrew Filer, Nagui Gendi, Alberto Cauli, Ernest Choy, Iain B. McInnes, Patrick Durez, Christopher J Edwards, Maya H Buch, Elisa Gremese, Peter C. Taylor, Nora Ng, Juan D. Cañete, Sabrina Raizada, Neil D McKay, Deepak R. Jadon, Pier Paolo Sainaghi, Richard Stratton, Michael R. Ehrenstein, Pauline Ho, Joaquim Polido‐Pereira, Bhaskar Dasgupta, Claire Gorman, James Galloway, Hector Chinoy, Désirée van der Heijde, Peter Sasieni, Anne Barton, Costantino Pitzalis, Ahmed S Zayat, Ana Rita Marinho Machado, Andrea Cuervo, Arti Mahto, Cankut Çubuk, Charlotte Rawlings, Chijioke H Mosanya, Christopher D. Buckley, Chris Holroyd, Debbie Maskall, Francesco Carlucci, Georgina Thorborn, Gina Tan, Gloria Lliso-Ribera, Hasan Rizvi, Joanna Peel, João Eurico Fonseca, John D. Isaacs, Julio Ramírez, Laurent Méric de Bellefon, Liliane Fossati-Jimak, Mary Ng’endo Githinji, Mattia Congia, Neal L. Millar, Nirupam Purkayastha, Raquel Celis, Rakhi Seth, Rebecca Hands-Greenwood, Robert Landewé, Simone Perniola, Stefano Alivernini, Stefano Marcia, Stefano Marini, Stephen Kelly, Vasco C. Romão - The Lancet Rheumatology 2023 cited by 68

  16. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

    Authors: Johan H. Thygesen, Christopher Tomlinson, Sam Hollings, Mehrdad A. Mizani, Álex Handy, Ashley Akbari, Amitava Banerjee, Jennifer Cooper, Alvina G. Lai, Kezhi Li, Bilal A. Mateen, Naveed Sattar, Reecha Sofat, Ana Torralbo, Honghan Wu, Angela Wood, Jonathan A C Sterne, Christina Pagel, William Whiteley, Cathie Sudlow, Harry Hemingway, Spiros Denaxas, Hoda Abbasizanjani, Nida Ahmed, Badar Ahmed, Badar Ahmed, Abdul Qadr Akinoso-Imran, Elias Allara, Freya Allery, Emanuele Di Angelantonio, Mark Ashworth, Vandana Ayyar Gupta, Sonya V. Babu‐Narayan, Seb Bacon, Steve Ball, Amitava Banerjee, Mark Barber, Jessica Barrett, Marion Bennie, Colin Berry, Jennifer Beveridge, Ewan Birney, Lana Bojanić, Thomas Bolton, Anna E Bone, Jon P. Boyle, Tasanee Braithwaite, Benjamin Bray, Norman Briffa, David Brind, Katherine Brown, Maya H Buch, Dexter Canoy, Massimo Caputo, Raymond Carragher, Alan Carson, Geneviève Cézard, J Chang, Kate Cheema, Richard Chin, Yogini Chudasama, Yogini Chudasama, Emma Copland, Rebecca Crallan, Rachel Cripps, David Cromwell, Vasa Ćurčin, Gwenetta Curry, Caroline Dale, John Danesh, Jayati Das‐Munshi, Ashkan Dashtban, Alun H. Davies, Joanna M. Davies, Gareth Davies, Neil M Davies, Joshua Day, Antonella Delmestri, Spiros Denaxas, Rachel Denholm, John Dennis, Alastair K. Denniston, Salil V. Deo, Baljean Dhillon, Annemarie B Docherty, Tim Dong, Abdel Douiri, Johnny Downs, Alex Dregan, Elizabeth A. Ellins, Martha Elwenspoek, Fabian Falck, Florian Falter, Yat Yi Fan, Joseph Firth, Lorna Fraser, Rocco Friebel, Amir Gavrieli, Moritz Gerstung, Ruth Gilbert and 206 more - The Lancet Digital Health 2022 cited by 83

  17. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

    Authors: Sofía Ramiro, C. Gaujoux-Viala, J. Nam, Josef S Smolen, Maya H Buch, Laure Gossec, Désirée van der Heijde, Kevin Winthrop, Robert Landewé - Annals of the Rheumatic Diseases 2014 cited by 711

  18. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

    Authors: Cosimo Bruni, Maya H Buch, Daniel E. Fürst, Giacomo De Luca, Aleksandra Djoković, Raluca B Dumitru, Alessandro Giollo, Marija Polovina, Alexia Steelandt, Kostantinos Bratis, Yossra A. Suliman, Ivan Milinković, Anna Baritussio, Ghadeer Hasan, Anastasia Xintarakou, Yohei Isomura, George Markousis‐Mavrogenis, Lorenzo Tofani, Sophie Mavrogeni, Luna Gargani, Alida L.P. Caforio, Carsten Tschöpe, Arsen Ristić, Karin Klingel, Sven Plein, Elijah R. Behr, Yannick Allanore, Masataka Kuwana, Christopher P. Denton, Dinesh Khanna, Thomas Krieg, R Marcolongo, Ilaria Galetti, Elisabetta Zanatta, Francesco Tona, Petar Seferović, Marco Matucci‐Cerinic - Journal of Scleroderma and Related Disorders 2021 cited by 75

  19. 'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps

    Authors: Yvonne Tan, Maya H Buch - RMD Open 2022 cited by 74

  20. B cell biomarkers of rituximab responses in systemic lupus erythematosus

    Authors: Edward M Vital, Shouvik Dass, Maya H Buch, Karen Henshaw, Colin Pease, Michael F. Martin, Frédérique Ponchel, Andy C. Rawstron, Paul Emery - Arthritis & Rheumatism 2011 cited by 236

  21. Transforming clinical trials in rheumatology: towards patient-centric precision medicine

    Authors: Costantino Pitzalis, Ernest Choy, Maya H Buch - Nature Reviews Rheumatology 2020 cited by 112

  22. Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

    Authors: Cosimo Bruni, Maya H Buch, Aleksandra Djoković, Giacomo De Luca, Raluca B Dumitru, Alessandro Giollo, Ilaria Galetti, Alexia Steelandt, Konstantinos Bratis, Yossra A. Suliman, Ivan Milinković, Anna Baritussio, Ghadeer Hasan, Anastasia Xintarakou, Yohei Isomura, George Markousis‐Mavrogenis, Sophie Mavrogeni, Luna Gargani, Alida L.P. Caforio, Carsten Tschöpe, Arsen Ristić, Sven Plein, Elijah R. Behr, Yannick Allanore, Masataka Kuwana, Christopher P. Denton, Daniel E. Furst, Dinesh Khanna, Thomas Krieg, R Marcolongo, Alessia Pepe, Oliver Distler, Petros P. Sfikakis, Petar Seferović, Marco Matucci‐Cerinic - Journal of Scleroderma and Related Disorders 2023 cited by 56

  23. Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

    Authors: Lianne Kearsley‐Fleet, Rebecca Davies, Diederik De Cock, Kath Watson, Mark Lunt, Maya H Buch, John D. Isaacs, Kimme L Hyrich - Annals of the Rheumatic Diseases 2018 cited by 169

  24. T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management

    Authors: Frédérique Ponchel, Agata Burska, Laura Hunt, Hanna Gul, Thibault Rabin, Rekha Parmar, Maya H Buch, Philip G. Conaghan, Paul Emery - Scientific Reports 2020 cited by 42